Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin

Yoji Murakami, Yoshihiro Wada, Hidetomo Kobayashi, Atsushi Irie, Makoto Hasegawa, Hiroyasu Yamanaka, Keinosuke Okamoto, Masatoshi Eto, Takahisa Imamura

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

ASP is a serine protease secreted by Aeromonas sobria. ASP cleaves various plasma proteins, which is associated with onset of sepsis complications, such as shock and blood coagulation disorder. To investigate a host defense mechanism against this virulence factor, we examined the plasma for ASP inhibitor(s). Human plasma inhibited ASP activity for azocasein, which was almost completely abolished by treating plasma with methylamine, which inactivates α2-macroglobulin (α2-MG). The ASP-inhibitor complex in ASP-added plasma was not detected by immunoblotting using anti-ASP antibody; however, using gel fi ltration of the plasma ASP activity for an oligopeptide, the ASP substrate was eluted in the void fraction (M w>200 000), suggesting ASP trapping by α2-MG. Indeed, human α2-MG inhibited ASP azocaseinolytic activity in a dose-dependent manner, rapidly forming a complex with the ASP. Fibrinogen degradation by ASP was completely inhibited in the presence of α2-MG. α1-Protease inhibitor, antithrombin, and α2-plasmin inhibitor neither inhibited ASP activity nor formed a complex with ASP. Surprisingly, ASP degraded these plasma serine protease inhibitors. Thus, α2-MG is the major ASP inhibitor in the human plasma and can limit ASP virulence activities in A. sobria infection sites. However, as shown by fluorescence correlation spectroscopy, slow ASP inhibition by α2-MG in plasma may indicate insuffi cient ASP control in vivo.

Original languageEnglish
Pages (from-to)1193-1200
Number of pages8
JournalBiological chemistry
Volume393
Issue number10
DOIs
Publication statusPublished - Oct 1 2012

Fingerprint

Aeromonas
Macroglobulins
Serine Proteases
Serine Proteinase Inhibitors
Plasmas
Plasma (human)
Blood Coagulation Disorders
Oligopeptides
Antifibrinolytic Agents

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Murakami, Y., Wada, Y., Kobayashi, H., Irie, A., Hasegawa, M., Yamanaka, H., ... Imamura, T. (2012). Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin. Biological chemistry, 393(10), 1193-1200. https://doi.org/10.1515/hsz-2012-0117

Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin. / Murakami, Yoji; Wada, Yoshihiro; Kobayashi, Hidetomo; Irie, Atsushi; Hasegawa, Makoto; Yamanaka, Hiroyasu; Okamoto, Keinosuke; Eto, Masatoshi; Imamura, Takahisa.

In: Biological chemistry, Vol. 393, No. 10, 01.10.2012, p. 1193-1200.

Research output: Contribution to journalArticle

Murakami, Y, Wada, Y, Kobayashi, H, Irie, A, Hasegawa, M, Yamanaka, H, Okamoto, K, Eto, M & Imamura, T 2012, 'Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin', Biological chemistry, vol. 393, no. 10, pp. 1193-1200. https://doi.org/10.1515/hsz-2012-0117
Murakami Y, Wada Y, Kobayashi H, Irie A, Hasegawa M, Yamanaka H et al. Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin. Biological chemistry. 2012 Oct 1;393(10):1193-1200. https://doi.org/10.1515/hsz-2012-0117
Murakami, Yoji ; Wada, Yoshihiro ; Kobayashi, Hidetomo ; Irie, Atsushi ; Hasegawa, Makoto ; Yamanaka, Hiroyasu ; Okamoto, Keinosuke ; Eto, Masatoshi ; Imamura, Takahisa. / Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin. In: Biological chemistry. 2012 ; Vol. 393, No. 10. pp. 1193-1200.
@article{df6c7bfe9fd040f699de525fede53092,
title = "Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin",
abstract = "ASP is a serine protease secreted by Aeromonas sobria. ASP cleaves various plasma proteins, which is associated with onset of sepsis complications, such as shock and blood coagulation disorder. To investigate a host defense mechanism against this virulence factor, we examined the plasma for ASP inhibitor(s). Human plasma inhibited ASP activity for azocasein, which was almost completely abolished by treating plasma with methylamine, which inactivates α2-macroglobulin (α2-MG). The ASP-inhibitor complex in ASP-added plasma was not detected by immunoblotting using anti-ASP antibody; however, using gel fi ltration of the plasma ASP activity for an oligopeptide, the ASP substrate was eluted in the void fraction (M w>200 000), suggesting ASP trapping by α2-MG. Indeed, human α2-MG inhibited ASP azocaseinolytic activity in a dose-dependent manner, rapidly forming a complex with the ASP. Fibrinogen degradation by ASP was completely inhibited in the presence of α2-MG. α1-Protease inhibitor, antithrombin, and α2-plasmin inhibitor neither inhibited ASP activity nor formed a complex with ASP. Surprisingly, ASP degraded these plasma serine protease inhibitors. Thus, α2-MG is the major ASP inhibitor in the human plasma and can limit ASP virulence activities in A. sobria infection sites. However, as shown by fluorescence correlation spectroscopy, slow ASP inhibition by α2-MG in plasma may indicate insuffi cient ASP control in vivo.",
author = "Yoji Murakami and Yoshihiro Wada and Hidetomo Kobayashi and Atsushi Irie and Makoto Hasegawa and Hiroyasu Yamanaka and Keinosuke Okamoto and Masatoshi Eto and Takahisa Imamura",
year = "2012",
month = "10",
day = "1",
doi = "10.1515/hsz-2012-0117",
language = "English",
volume = "393",
pages = "1193--1200",
journal = "Biological Chemistry",
issn = "1431-6730",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "10",

}

TY - JOUR

T1 - Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin

AU - Murakami, Yoji

AU - Wada, Yoshihiro

AU - Kobayashi, Hidetomo

AU - Irie, Atsushi

AU - Hasegawa, Makoto

AU - Yamanaka, Hiroyasu

AU - Okamoto, Keinosuke

AU - Eto, Masatoshi

AU - Imamura, Takahisa

PY - 2012/10/1

Y1 - 2012/10/1

N2 - ASP is a serine protease secreted by Aeromonas sobria. ASP cleaves various plasma proteins, which is associated with onset of sepsis complications, such as shock and blood coagulation disorder. To investigate a host defense mechanism against this virulence factor, we examined the plasma for ASP inhibitor(s). Human plasma inhibited ASP activity for azocasein, which was almost completely abolished by treating plasma with methylamine, which inactivates α2-macroglobulin (α2-MG). The ASP-inhibitor complex in ASP-added plasma was not detected by immunoblotting using anti-ASP antibody; however, using gel fi ltration of the plasma ASP activity for an oligopeptide, the ASP substrate was eluted in the void fraction (M w>200 000), suggesting ASP trapping by α2-MG. Indeed, human α2-MG inhibited ASP azocaseinolytic activity in a dose-dependent manner, rapidly forming a complex with the ASP. Fibrinogen degradation by ASP was completely inhibited in the presence of α2-MG. α1-Protease inhibitor, antithrombin, and α2-plasmin inhibitor neither inhibited ASP activity nor formed a complex with ASP. Surprisingly, ASP degraded these plasma serine protease inhibitors. Thus, α2-MG is the major ASP inhibitor in the human plasma and can limit ASP virulence activities in A. sobria infection sites. However, as shown by fluorescence correlation spectroscopy, slow ASP inhibition by α2-MG in plasma may indicate insuffi cient ASP control in vivo.

AB - ASP is a serine protease secreted by Aeromonas sobria. ASP cleaves various plasma proteins, which is associated with onset of sepsis complications, such as shock and blood coagulation disorder. To investigate a host defense mechanism against this virulence factor, we examined the plasma for ASP inhibitor(s). Human plasma inhibited ASP activity for azocasein, which was almost completely abolished by treating plasma with methylamine, which inactivates α2-macroglobulin (α2-MG). The ASP-inhibitor complex in ASP-added plasma was not detected by immunoblotting using anti-ASP antibody; however, using gel fi ltration of the plasma ASP activity for an oligopeptide, the ASP substrate was eluted in the void fraction (M w>200 000), suggesting ASP trapping by α2-MG. Indeed, human α2-MG inhibited ASP azocaseinolytic activity in a dose-dependent manner, rapidly forming a complex with the ASP. Fibrinogen degradation by ASP was completely inhibited in the presence of α2-MG. α1-Protease inhibitor, antithrombin, and α2-plasmin inhibitor neither inhibited ASP activity nor formed a complex with ASP. Surprisingly, ASP degraded these plasma serine protease inhibitors. Thus, α2-MG is the major ASP inhibitor in the human plasma and can limit ASP virulence activities in A. sobria infection sites. However, as shown by fluorescence correlation spectroscopy, slow ASP inhibition by α2-MG in plasma may indicate insuffi cient ASP control in vivo.

UR - http://www.scopus.com/inward/record.url?scp=84867582547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867582547&partnerID=8YFLogxK

U2 - 10.1515/hsz-2012-0117

DO - 10.1515/hsz-2012-0117

M3 - Article

C2 - 23089609

AN - SCOPUS:84867582547

VL - 393

SP - 1193

EP - 1200

JO - Biological Chemistry

JF - Biological Chemistry

SN - 1431-6730

IS - 10

ER -